Arbutus Biopharma Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Insights

Arbutus Biopharma Corp. (ABUS)

4.64 +0.29 (+6.67%) USD | NASDAQ | May 26, 16:00

4.64 0.00 (0.00%) After-Hours: 20:00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) for ABUS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Portion of LTD and Capital Lease Obligation (Quarterly) Benchmarks

Start Trial

Moderna, Inc.	Upgrade
Vertex Pharmaceuticals, Inc.	Upgrade
ACADIA Pharmaceuticals, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Amgen, Inc.	Upgrade